fda import alert semaglutide tirzepatide green list Moves to Close a Compounded GLP-1 Loophole: What the 503B Proposal Means for Patients FDA Import Alert 66-80: GLP-1

High adherence was reported by 79% of participants

What remains are warnings against use during pregnancy and lactation, grounded in animal teratogenicity signals and the principle of avoiding unnecessary medication exposure during sensitive developmental windows

Both GIP and GLP-1 receptors are expressed throughout the gastrointestinal tract, and their activation produces multiple effects that can alter bowel function and stool consistency

Second, VAS score was a subjective outcome and could be significantly affected by both patients and physicians

Its metabolic medicine

not incredibly profound, but just enough to give it teeth